title: [The use of mildronat in heart failure in patients with chronic ischemic heart disease].
abstract: A new native cardioprotector mildronat was used for the treatment of cardiac insufficiency due to ischemic heart disease. It was established that mildronate produced a positive effect on the hemodynamics and gaseous composition of the blood. The patients also showed normalization of the nitrogen metabolism and activity of the membrane-bound erythrocytic enzymes.
authors.forename: I I
authors.initials: II
authors.lastname: Sakharchuk
authors.forename: G T
authors.initials: GT
authors.lastname: Denisenko
authors.forename: V S
authors.initials: VS
authors.lastname: Grushko
authors.forename: O I
authors.initials: OI
authors.lastname: Bodaretskaia
authors.forename: A N
authors.initials: AN
authors.lastname: Pishchalenko
mesh_terms: D002317:Cardiovascular Agents / Q000627:therapeutic use*; D002908:Chronic Disease; D003327:Coronary Disease / Q000097:blood / Q000150:complications* / Q000188:drug therapy; D004341:Drug Evaluation; D006333:Heart Failure / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D006899:Mixed Function Oxygenases / Q000037:antagonists & inhibitors; D050563:gamma-Butyrobetaine Dioxygenase
chemical_list: D002317:Cardiovascular Agents; D006899:Mixed Function Oxygenases; D050563:gamma-Butyrobetaine Dioxygenase
vernacular_title: Primenenie mildronata pri serdechnoĭ nedostatochnosti u bol'nykh khronicheskoĭ ishemicheskoĭ bolezn'iu serdtsa.